Table 1.

Melanoma patient characteristics of the OS cohort

(n = 104)
Clinical characteristics
Gender, n (%)
 Male75 (72.1)
 Female29 (27.9)
Age, n (range)
 Median74.5 (22–96)
Location of tumor, n (%)
 Trunk61 (58.7)
 Extremity41 (39.4)
 Unknown2 (1.9)
Stage, n (%)
 II91 (87.5)
 III13 (12.5)
Pathologic characteristics
Depth (mm)
 Median, n (range)2.5 (0.6–26)
Ulceration, n (%)
 Absent36 (34.6)
 Present65 (62.5)
 Unknown3 (2.9)
TILs, n (%)
 Absent2 (1.9)
 Non-brisk59 (56.8)
 Brisk33 (31.7)
 Unknown10 (9.6)
Outcome characteristics
Patient follow-up (months)
 Median, n (range)45 (4–173)
OS (months)
 Alive (at least 2 years), n (%)31 (29.8)
 Dead, n (%)73 (70.2)
DSS (months)
 Alive or NED at death, n (%)42 (40.4)
 Dead with melanoma, n (%)22 (21.2)
 Unknown, n (%)40 (38.4)
  • Abbreviations: DSS, disease-specific survival; NED, no evidence of disease; TILs, tumor-infiltrating lymphocytes.